To investigate telomere changes in patients with aplastic anaemia (AA) and
clinical factors influencing the telomere dynamics, telomere length (TL) wa
s measured in peripheral blood mononuclear cells using Southern blot analys
is of 42 patients with AA and 39 healthy normal controls. Nineteen patients
received supportive treatment only while the remaining 23 patients receive
d immunosuppressive therapy with anti-thymocyte globulin or antilymphocyte
globulin +/-cyclosporin A. In AA patients, TL was on average 1.41 kb shorte
r than that of age-matched normal controls (P < 0.001). In patients treated
with immunosuppression, the mean TL of non-responders was significantly sh
orter than that of age-matched normal controls (P < 0.001), while no differ
ence in TL was detected in responders compared with controls. Positive corr
elation was observed between the extent of telomere shortening, the severit
y of neutropenia (P = 0.05) and the degree of mean corpuscular volume eleva
tion (P = 0.005) at the time of the study. However, there was no correlatio
n with time elapsed since diagnosis (P = 0.214). These findings suggest tha
t haematopoietic stern cells in patients with AA rapidly lose TL at the ons
et of the disease. The TL shortening may reflect the severity of impairment
of haematopoiesis.